Creative Planning’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,784
| Closed | -$1.2M | – | 2188 |
|
|
2020
Q1 | $1.2M | Sell |
6,784
-729
| -10% | -$137K | ﹤0.01% | 576 |
|
|
2019
Q4 | $1.44M | Sell |
7,513
-1,562
| -17% | -$282K | ﹤0.01% | 641 |
|
|
2019
Q3 | $1.53M | Sell |
9,075
-2,669
| -23% | -$435K | 0.01% | 584 |
|
|
2019
Q2 | $1.97M | Buy |
11,744
+1,746
| +17% | +$242K | 0.01% | 503 |
|
|
2019
Q1 | $1.46M | Sell |
9,998
-1,765
| -15% | -$256K | 0.01% | 580 |
|
|
2018
Q4 | $1.57M | Sell |
11,763
-2,689
| -19% | -$441K | 0.01% | 488 |
|
|
2018
Q3 | $2.75M | Sell |
14,452
-2,991
| -17% | -$549K | 0.01% | 398 |
|
|
2018
Q2 | $2.91M | Sell |
17,443
-851
| -5% | -$137K | 0.01% | 382 |
|
|
2018
Q1 | $3.08M | Sell |
18,294
-507
| -3% | -$85K | 0.01% | 357 |
|
|
2017
Q4 | $3.08M | Sell |
18,801
-1,460
| -7% | -$262K | 0.01% | 348 |
|
|
2017
Q3 | $4.15M | Buy |
20,261
+4,250
| +27% | +$988K | 0.02% | 273 |
|
|
2017
Q2 | $3.89M | Sell |
16,011
-2,295
| -13% | -$539K | 0.02% | 271 |
|
|
2017
Q1 | $4.37M | Sell |
18,306
-4,460
| -20% | -$1.04M | 0.02% | 230 |
|
|
2016
Q4 | $4.78M | Buy |
22,766
+1,556
| +7% | +$322K | 0.03% | 211 |
|
|
2016
Q3 | $4.88M | Buy |
21,210
+2,799
| +15% | +$684K | 0.03% | 208 |
|
|
2016
Q2 | $4.25M | Buy |
18,411
+5,283
| +40% | +$1.22M | 0.03% | 190 |
|
|
2016
Q1 | $3.52M | Sell |
13,128
-7,360
| -36% | -$2.11M | 0.03% | 200 |
|
|
2015
Q4 | $6.4M | Buy |
20,488
+572
| +3% | +$170K | 0.05% | 137 |
|
|
2015
Q3 | $5.41M | Buy |
19,916
+513
| +3% | +$158K | 0.05% | 156 |
|
|
2015
Q2 | $5.89M | Sell |
19,403
-5,455
| -22% | -$1.63M | 0.05% | 135 |
|
|
2015
Q1 | $7.4M | Buy |
24,858
+9,799
| +65% | +$2.79M | 0.07% | 117 |
|
|
2014
Q4 | $3.88M | Buy |
15,059
+1,400
| +10% | +$350K | 0.04% | 166 |
|
|
2014
Q3 | $3.3M | Buy |
13,659
+1,743
| +15% | +$390K | 0.04% | 172 |
|
|
2014
Q2 | $2.66M | Sell |
11,916
-939
| -7% | -$194K | 0.03% | 188 |
|
|
2014
Q1 | $2.65M | Buy |
12,855
+4,931
| +62% | +$977K | 0.04% | 161 |
|
|
2013
Q4 | $1.33M | Buy |
+7,924
| New | +$1.24M | 0.02% | 251 |
|
|
2013
Q3 | – | Sell |
-3,370
| Closed | -$425K | – | 3409 |
|
|
2013
Q2 | $425K | Buy |
+3,370
| New | +$382K | 0.01% | 446 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Creative Planning's AGN Position: Q2 2020 in Review
Creative Planning sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,784 shares — an estimated $1.2M sold.
Creative Planning first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $7.4M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Creative Planning reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Creative Planning sold 6,784 Allergan plc shares in Q2 2020, an estimated $1.2M.
- Creative Planning first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
- Creative Planning's Allergan plc position peaked at $7.4M in Q1 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.